WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware

MIDDLETOWN,Del.,Aug. 17,2022 -- WuXi STA,a leading Contract Research,Development,and Manufacturing Organization (CRDMO),is pleased to announce the groundbreaking for its new 190-acre pharmaceutical manufacturing campus in Middletown,Delaware. First announced in June 2021,this site will be WuXi STA's second facility in the United States,offering expanded capacity and greater flexibility to meet the needs of customers in the U.S. and around the world.

Governor John Carney,Lieutenant Governor Bethany Hall-Long,Mayor Kenneth Branner,Jr.,Delaware Prosperity Partnership President Kurt Foreman,WuXi AppTec Chairman and CEO Dr. Ge Li,WuXi AppTec Co-CEO and WuXi STA CEO Dr. Minzhang Chen,and others celebrate the groundbreaking for the WuXi STA Middletown campus.

The WuXi STA Middletown site is located in the Middletown Business Center at 1091 Industrial Drive,and the new state-of-the-art facility will create approximately 500 full-time jobs by 2026. Phase I of the new campus will provide formulation development,clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms,as well as packaging,labeling,storage and distribution services for clinical trial materials and commercial drug products.

WuXi STA has 12 sites across the U.S.,Europe and Asia that offer a range of services and meet or exceed all regulatory standards. Together with three other drug product manufacturing sites in Couvet (Switzerland),Wuxi City (China) and Shanghai (China),this new facility will further enhance the company's global drug production capacity and capabilities.

"The biopharmaceutical industry is part of Delaware's DNA," said Delaware Governor John Carney. "Over the next five years,WuXi STA plans to build a state-of-the-art pharmaceutical manufacturing campus in one of Delaware's fastest-growing communities,bringing with it good jobs and economic growth. This campus is only possible because of Delaware's world-class,innovative workforce. Thank you to WuXi STA,Middletown Mayor Kenny Branner and everyone who made this project possible."

"The First State continues to be a first-rate destination for businesses looking to innovate and grow," said Senator Tom Carper. "This investment by WuXi STA helps position Delaware as a continued global leader in biopharmaceuticals,further cementing the manufacturing might of one of our fastest growing communities. Delaware's workforce is ready to help build the future of our life-saving pharmaceuticals. This state-of-the-art campus will create good jobs and help fortify our supply chains here at home."

"This biopharmaceutical facility is one most significant private sector investment ever in the Middletown region," said Senator Chris Coons. "I am excited about WuXi STA's decision to choose Middletown for one of their new manufacturing facilities. This isn't just the largest private-sector investment in Middletown's history – it's a defining moment that will bring many more good-paying jobs to Delaware and will further cement the First State as a world leader in biopharmaceutical research and manufacturing. Thanks are due to everyone from Middletown to Dover to Washington who helped us get to this point,whether by making continued investments in NIIMBL,improving our education system from kindergarten to our universities,or ensuring that Delaware workers have the skills manufacturers like WuXi AppTec are looking for."

"As the First State,Delaware has always had a spirit of innovation – constantly seeking new opportunities and ventures that will strengthen our economy and our state as a whole," said Rep. Lisa Blunt Rochester. "Today's groundbreaking of the WuXi STA pharmaceutical manufacturing plant represents another step in that spirit of innovation – bringing good-paying jobs to Middletown and strengthening communities throughout Delaware. The state-of-the-art facility will bring 500 full-time jobs over the next several years,growing our state's workforce and allowing us to manufacture more goods domestically - enhancing our economic competitiveness on the global stage."

"We are truly looking forward to our partnership with WuXi STA,as the groundbreaking today marks the kick-off to them making their new home in Middletown,Delaware. WuXi STA will be joining our bustling industrial area,just steps away from Clarios,Datwyler,Amazon and Breakthru Beverage,just some of the companies that have invested in Middletown. When asked by WuXi STA about our business-friendly attitude,these businesses expressed their wholehearted support for how we do business and we couldn't be more excited about WuXi STA wanting to join them,and the Town of Middletown,in our journey together," said Middletown Mayor Ken Branner. Branner added he was thankful for the support of Gov. John Carney and the Delaware Prosperity Partnership.

"I would like to thank our federal,state and local partners in Delaware for their continued support in the establishment of this site," said Dr. Minzhang Chen,co-CEO of WuXi AppTec and CEO of WuXi STA. "WuXi STA continues to increase our capabilities and capacities to better serve our customers through a more robust and reliable supply chain. With our integrated Contract Research,and Manufacturing Organization (CRDMO) platform and proven quality system,we look forward to working with our customers to swiftly deliver their innovative therapies to market in order to save lives and improve healthcare for patients."

The WuXi STA Middletown facility is expected to begin operations in 2025.

About WuXi STA

WuXi STA (stapharma.com),a subsidiary of WuXi AppTec (wuxiapptec.com),is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry,with global operations. As a premier Contract Research,WuXi STA offers its worldwide partners efficient,flexible and high-quality solutions for integrated chemical,manufacturing and controls (CMC) from preclinical to commercial uses,including the development and manufacturing of small molecule,oligonucleotide,peptide and various complex chemical conjugate. For more information,please visit: http://www.STApharma.com

About WuXi AppTec

As a global company with operations across Asia,Europe,and North America,WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models,WuXi AppTec's integrated,end-to-end services include chemistry drug CRDMO (Contract Research,Development and Manufacturing Organization),biology discovery,preclinical testing and clinical research services,cell and gene therapies CTDMO (Contract Testing,helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its open-access platform is enabling more than 5,850 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com

Media Contact:

Davy Wu

mediainquiries@wuxiapptec.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wuxi-sta-breaks-ground-for-new-pharmaceutical-manufacturing-facility-in-middletown-delaware-301606907.html